These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 11286015

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.
    O-Charoenrat P, Rhys-Evans PH, Eccles SA.
    Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):813-20. PubMed ID: 11448356
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder.
    Durkan GC, Nutt JE, Rajjayabun PH, Neal DE, Lunec J, Mellon JK.
    Clin Cancer Res; 2001 Nov; 7(11):3450-6. PubMed ID: 11705862
    [Abstract] [Full Text] [Related]

  • 4. Matrix metalloproteinases in tumour invasion and metastasis.
    Curran S, Murray GI.
    J Pathol; 1999 Nov; 189(3):300-8. PubMed ID: 10547590
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX, Li L, Li DR, Zhang W, Cheng XQ, Zhang JQ, Tang BJ.
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The role of the IGF-I receptor in the regulation of matrix metalloproteinases, tumor invasion and metastasis.
    Zhang D, Samani AA, Brodt P.
    Horm Metab Res; 2003 Oct; 35(11-12):802-8. PubMed ID: 14710361
    [Abstract] [Full Text] [Related]

  • 12. Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells.
    Chang CC, Shieh GS, Wu P, Lin CC, Shiau AL, Wu CL.
    Cancer Res; 2008 Aug 01; 68(15):6281-91. PubMed ID: 18676852
    [Abstract] [Full Text] [Related]

  • 13. Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade.
    Bianco FJ, Gervasi DC, Tiguert R, Grignon DJ, Pontes JE, Crissman JD, Fridman R, Wood DP.
    Clin Cancer Res; 1998 Dec 01; 4(12):3011-6. PubMed ID: 9865914
    [Abstract] [Full Text] [Related]

  • 14. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder.
    Hara I, Miyake H, Hara S, Arakawa S, Kamidono S.
    J Urol; 2001 May 01; 165(5):1769-72. PubMed ID: 11342973
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis.
    Forget MA, Desrosiers RR, Béliveau R.
    Can J Physiol Pharmacol; 1999 Jul 01; 77(7):465-80. PubMed ID: 10535707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.